Designed to make market research more actionable and strategically valuable, The Business Research Company’s 2026 market reports feature market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Smart Life Sciences Manufacturing Market Forecast 2026–2030: Size, Value And Compound Annual Growth Rate
The smart life sciences manufacturing market has experienced rapid expansion in recent years. It is projected to increase from $28.59 billion in 2025 to $32.83 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. Historically, this growth can be attributed to factors including the increasing complexity of life sciences manufacturing processes, heightened regulatory scrutiny on product quality, the expansion of pharmaceutical and biopharma production capacity, the early adoption of automation technologies, and a growing demand for manufacturing traceability.
The smart life sciences manufacturing market is projected to experience swift expansion over the coming years. Its market size is anticipated to reach $59.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.9%. This growth during the forecast period stems from factors such as augmented investments in intelligent pharmaceutical facilities, a greater uptake of digital twin solutions, the expansion of personalized medicine production, the deepening incorporation of AI-powered quality analytics, and a heightened emphasis on supply chain transparency and robustness. Key developments expected within the same period encompass a wider embrace of digital manufacturing execution systems, increased embedding of IoT-enabled production monitoring, the expanding application of advanced data analytics for process refinement, the broadening deployment of automation and robotics in pharmaceutical production, and an intensified commitment to regulatory adherence and quality assurance.
Try Before You Buy: Free Sample Of The Smart Life Sciences Manufacturing Market Report:
Smart Life Sciences Manufacturing Market Growth Engine: The Factor Boosting Demand Globally
The increasing need for personalized medicine is projected to stimulate the growth of the smart life sciences manufacturing market moving forward. Personalized medicine refers to a medical and healthcare strategy that customizes medical decisions, practices, interventions, and therapies specifically for individual patients. This growing demand for personalized medicine is prompting the life sciences industry to adopt smart manufacturing technologies and processes to enable the efficient, precise, and flexible production of customized pharmaceuticals and therapies, thereby improving treatment outcomes. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. The newly approved personalized treatments for 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the rising demand for personalized medicine is a key driver for the expansion of the smart life sciences manufacturing market.
Which Categories And Subcategories Shape The Smart Life Sciences Manufacturing Market?
The smart life sciences manufacturing market covered in this report is segmented –
1) By Component: Solution, Services
2) By Technology: Internet of Things (IoT), Artificial Intelligence, Cybersecurity, Big Data, Other Technologies
3) By Application: Pharma, Bio-Pharma, Medical Device
Subsegments:
1) By Solution: Manufacturing Execution Systems (MES), Quality Management Systems (QMS), Automation and Control, Data Analytics And Reporting
2) By Services: Consulting Services, Integration And Implementation, Maintenance and Support
Smart Life Sciences Manufacturing Market Trend Insights: Strategic Focus Areas Of Leading Companies
Major market players are concentrating their efforts on creating innovative artificial intelligence (AI) medical technologies to sustain their position in the market. AI-based advancements are crucial in smart life science for analyzing and interpreting vast amounts of data, streamlining processes, and enabling more personalized engagement. For instance, in May 2023, Google Cloud Platform LLC, a US-based technology company, launched two new AI-powered solutions aimed at accelerating drug discovery and precision medicine. These innovative tools can help researchers discover new drugs faster and more efficiently. Additionally, these tools are capable of improving the accuracy of drug development and reducing the cost of bringing new drugs to market. Moreover, this development has the potential to accelerate the growth of new drugs and ultimately improve patients’ lives.
Leading Organizations In The Smart Life Sciences Manufacturing Market
Major companies operating in the smart life sciences manufacturing market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Novartis AG, Merck and Co Inc, Sanofi S A, GlaxoSmithKline plc, AstraZeneca plc, Bristol Myers Squibb, Eli Lilly and Company, AbbVie Inc, Amgen Inc, Gilead Sciences Inc, Biogen Inc, Takeda Pharmaceutical Company Limited, Bayer AG, Boehringer Ingelheim, Novo Nordisk A S, Teva Pharmaceutical Industries Ltd, CSL Limited
Continue Reading: The Full Smart Life Sciences Manufacturing Market Report:
Smart Life Sciences Manufacturing Market Regional Spotlight: Top Geography And Report Coverage
North America was the largest region in the smart life sciences manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart life sciences manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
